Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	127
Total, all-cause mortality	Astegolimab (MSTT1041A) 70mg	0	127
Total, all-cause mortality	Astegolimab (MSTT1041A) 210mg	1	126
Total, all-cause mortality	Astegolimab (MSTT1041A) 490mg	1	122
Total, other adverse events	Placebo	76	127
Total, other adverse events	Astegolimab (MSTT1041A) 70mg	65	127
Total, other adverse events	Astegolimab (MSTT1041A) 210mg	75	126
Total, other adverse events	Astegolimab (MSTT1041A) 490mg	68	122
Total, serious adverse events	Placebo	8	127
Total, serious adverse events	Astegolimab (MSTT1041A) 70mg	14	127
Total, serious adverse events	Astegolimab (MSTT1041A) 210mg	9	126
Total, serious adverse events	Astegolimab (MSTT1041A) 490mg	6	122

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02918019/event-totals